# EDGAR Filing Document

**Accession Number:** 0000769218
**File Stem:** 0001193125-26-183867
**Filing Date:** 2026-4
**Character Count:** 18271
**Document Hash:** b726d3fe490dcbf913bc0151d3ac3110
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-183867.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001193125-26-183867

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260428

**FILED AS OF DATE**: 20260428

**DATE AS OF CHANGE**: 20260428

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AEGON LTD.
- **CENTRAL INDEX KEY:** 0000769218
- **STANDARD INDUSTRIAL CLASSIFICATION:** LIFE INSURANCE [6311]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 000000000
- **STATE OF INCORPORATION:** D0
- **FISCAL YEAR END:** 1231
- **LEGAL ENTITY IDENTIFIER:** O4QK7KMMK83ITNTHUG69

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10882
- **FILM NUMBER:** 26903433

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** WORLD TRADE CENTER SCHIPHOL
- **STREET 2:** SCHIPHOL BOULEVARD 223
- **CITY:** SCHIPHOL
- **PROVINCE COUNTRY:** P7
- **ZIP:** 1118 BH
- **BUSINESS PHONE:** 011-31-20-259-2500

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** WORLD TRADE CENTER SCHIPHOL
- **STREET 2:** SCHIPHOL BOULEVARD 223
- **CITY:** SCHIPHOL
- **PROVINCE COUNTRY:** P7
- **ZIP:** 1118 BH

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AEGON NV
- **DATE OF NAME CHANGE:** 19970423

**Securities and Exchange Commission** 

**Washington, D.C. 20549** 

**Form 6-K** 

**Report of Foreign Issuer** 

**Pursuant to Rule 13a-16 or 15d/16** 

**of the Securities Exchange Act of 1934** 

**April 2026** 

## Aegon Ltd.

---

| | | | |
|:---|:---|:---|:---|
| **Aegon Limited** | **Statutory seat** | **Principal place of business** | Bermuda Registrar of Companies number: 202302830 |
| An exempted company with liability | Canon's Court | World Trade Center | (September 30, 2023) |
| limited by shares | 22 Victoria Street | Schiphol Boulevard 223 | Dutch Chamber of Commerce number: 27076669 |
|  | Hamilton HM 12 | 1118 BH Schiphol | Aegon Limited is a non-resident company under the Dutch |
| www.aegon.com | Bermuda | The Netherlands | Act Non Residential Companies |

---

The Unaudited Pro Forma Consolidated Financial Information and notes thereto of Aegon Ltd. (the "Company") herein are hereby incorporated by reference in the Company's Registration Statements under the Securities Act of 1933, as amended, on Form F-3 (Registration No. 333-287291, 333-287291-01) and on Form S-8 (Registration Nos. 333-238186, 333-196156, 333-183176, 333-157843, and 333-150774).

------

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | Aegon Ltd. | Aegon Ltd. |
|  | (Registrant) | (Registrant) |
| Date: April 28, 2026 | By | /s/ S. Knol |
|  | S. Knol | S. Knol |
|  | Director Financial Reporting & Operations | Director Financial Reporting & Operations |

---

------

**Unaudited pro forma consolidated financial information of Aegon Ltd. relating to the** 

**proposed sale of the Aegon UK plc** 

**As of December 31, 2025 and for the years ended December 31, 2025, 2024 and 2023** 

**Introductory paragraph** 

The unaudited pro forma consolidated financial information presented below illustrates the financial impact on Aegon Ltd.'s (Aegon) consolidated statement of financial position as of December 31, 2025 and consolidated income statements for the years ended December 31, 2025, 2024 and 2023 of the proposed sale of Aegon UK plc ("Aegon UK") containing the UK insurance and pensions operations to Standard Life Plc ("Standard Life"), a publicly traded company on the London stock exchange, that was announced on April 15, 2026. In connection with such sale, Aegon will receive GBP 750 million in gross cash proceeds and a 15.3% shareholding in Standard Life ordinary shares, with associated governance rights. Any remittances taken out of Aegon UK between the signing and closing of the transaction will be deducted from the GBP 750 million cash amount. Aegon's asset management activities in the UK will remain part of Aegon's global asset manager and will be an important asset management partner for the new combined business.

The transaction is expected to close around the end of 2026, subject to customary conditions, including regulatory approvals. The assets and liabilities of Aegon UK will be classified, for purposes of Aegon's 1H 2026 consolidated financial statements, as held for sale. Related result will be presented as results from discontinued operations.

The unaudited pro forma consolidated financial information below complies with Article 11 of Regulation S-X and illustrates the impact of the proposed sale of Aegon UK on Aegon's consolidated statement of financial position as of December 31, 2025 and Aegon's consolidated income statements for the years ended December 31, 2025, 2024 and 2023. The unaudited pro forma consolidated statement of financial position has been prepared as if the sale had been consummated as of December 31, 2025. The unaudited pro forma consolidated income statements have been prepared as if the sale had been consummated as of January 1 of the respective years.

Historical financial information contains Aegon Ltd.'s audited consolidated financial information as presented in the Annual Report on Form 20-F 2025. The pro forma adjustments represent the financial impact of the proposed sale as described above. Pro forma adjustments are consistent with Aegon's applicable financial reporting framework disclosed in the Annual Report 2025 on Form 20-F and with its accounting policies.

In each case, the pro forma data financial information is presented for illustrative purposes only and should not be relied upon as an indication of the financial condition or the operating results that would have been achieved if the Sale had taken place on the specified dates. In addition, future results may vary significantly from the results reflected in such pro forma financial information data and should not be relied on as an indication of future results.

Further information on the pro forma adjustments can be found in the notes to this unaudited pro forma financial information.

------

**Unaudited pro forma Consolidated Income Statements of Aegon Ltd.** 

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | **For the year ended December 31, 2025** | **For the year ended December 31, 2025** | **For the year ended December 31, 2025** | **For the year ended December 31, 2024** | **For the year ended December 31, 2024** | **For the year ended December 31, 2024** | **For the year ended December 31, 2023** | **For the year ended December 31, 2023** | **For the year ended December 31, 2023** |
| Amounts in EUR millions (except per share data) | **Note** | **Historical** | **Pro forma<br>adjustments** | <br> **Pro forma<br>financial<br>information** | **Historical** | **Pro forma<br>adjustments** | **Pro forma<br>financial<br>information** | **Historical** | **Pro forma<br>adjustments** | **Pro forma<br>financial<br>information** |
|  *Continuing operations* |  |  |  |  |  |  |  |  |  |  |
|  Insurance revenue |  | 9097 | 422 | 8675 | 9841 | 543 | 9298 | 10386 | 663 | 9722 |
|  Insurance service expenses |  | (9423) | (183) | (9239) | (9790) | (302) | (9487) | (10226) | (406) | (9820) |
|  Net income / (expenses) on reinsurance held |  | 836 | (1) | 837 | 325 | (28) | 353 | 182 | (61) | 243 |
|  **Insurance service result** | **1** | **511** | **238** | **272** | **376** | **213** | **163** | **342** | **197** | **145** |
|  Interest revenue on financial instruments calculated using the effective interest method |  | 2683 | 27 | 2657 | 2720 | 32 | 2688 | 2738 | 25 | 2713 |
|  Interest income from instruments measured at FVPL |  | 615 | 389 | 226 | 637 | 355 | 282 | 737 | 397 | 340 |
|  Other investment income |  | 1198 | 1188 | 11 | 1340 | 1329 | 10 | 1283 | 1272 | 11 |
|  Results from financial transactions |  | 15632 | 6965 | 8667 | 11593 | 4196 | 7398 | 12302 | 3992 | 8310 |
|  Impairment (losses) / reversals |  | (46) | - | (46) | (190) | - | (190) | (86) | - | (86) |
|  Insurance finance income / (expenses) |  | (20227) | (8645) | (11582) | (16506) | (5945) | (10561) | (17650) | (5737) | (11913) |
|  Net reinsurance finance income / (expenses) on reinsurance held |  | 564 | (4) | 568 | 611 | (19) | 630 | 699 | 6 | 693 |
|  Interest expenses |  | (135) | - | (135) | (171) | - | (171) | (218) | - | (218) |
|  **Insurance net investment result** | **2** | **285** | **(81)** | **366** | **34** | **(53)** | **87** | **(196)** | **(45)** | **(151)** |
|  Interest revenue on financial instruments calculated using the effective interest method |  | 636 | 37 | 600 | 605 | 44 | 562 | 599 | 33 | 566 |
|  Interest income from instruments measured at FVPL |  | 217 | 129 | 88 | 186 | 108 | 78 | 89 | 89 | - |
|  Other investment income |  | 825 | 821 | 5 | 729 | 721 | 8 | 550 | 546 | 4 |
|  Results from financial transactions |  | 10065 | 6032 | 4033 | 7634 | 4280 | 3354 | 6929 | 3267 | 3663 |
|  Impairment (losses) / reversals |  | (22) | - | (22) | (47) | - | (47) | (33) | - | (33) |
|  Investment contract income / (expenses) |  | (11372) | (6994) | (4378) | (8781) | (5130) | (3651) | (7851) | (3896) | (3955) |
|  Interest expenses |  | (18) | 1 | (19) | (32) | (1) | (31) | (45) | (3) | (42) |
|  **Other net investment result** | **3** | **331** | **26** | **306** | **294** | **22** | **272** | **238** | **36** | **203** |
|  Interest charges |  | (178) | - | (178) | (190) | - | (190) | (182) | - | (182) |
|  **Financing net investment result** |  | **(178)** | **-** | **(178)** | **(190)** | **-** | **(190)** | **(182)** | **-** | **(182)** |
|  **Total net investment result** |  | **438** | **(55)** | **493** | **139** | **(31)** | **169** | **(139)** | **(9)** | **(130)** |
|  Fees and commission income |  | 2390 | 311 | 2079 | 2378 | 283 | 2096 | 2163 | 214 | 1949 |
|  Other operating expenses |  | (2928) | (392) | (2536) | (2961) | (378) | (2583) | (3000) | (311) | (2689) |
|  Other income / (charges) |  | 130 | 10 | 120 | 145 | 52 | 93 | (57) | 4 | (61) |
|  **Other result** |  | **(408)** | **(70)** | **(337)** | **(438)** | **(44)** | **(394)** | **(894)** | **(93)** | **(801)** |
|  **Result before share in profit / (loss) of joint ventures, associates and tax** |  | **541** | **113** | **428** | **77** | **139** | **(62)** | **(691)** | **95** | **(785)** |
|  Share in profit / (loss) of joint ventures |  | 303 | - | 303 | 238 | - | 238 | 196 | - | 196 |
|  Share in profit / (loss) of associates |  | 200 | - | 200 | 345 | - | 345 | 103 | - | 103 |
|  **Result before tax from continuing operations** |  | **1045** | **113** | **932** | **660** | **139** | **521** | **(391)** | **95** | **(486)** |
|  Income tax (expense) / benefit |  | (65) | (32) | (32) | 16 | (16) | 32 | 209 | (23) | 232 |
|  **Net result from continuing operations** | **4** | **980** | **81** | **900** | **676** | **123** | **553** | **(182)** | **72** | **(254)** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | 2025 | 2025 | 2024 | 2024 | 2023 | 2023 |
|  | **Historical** | **Pro forma financial<br>information** | **Historical** | **Pro forma financial<br>information** | **Historical** | **Pro forma financial<br>information** |
|  Basic earnings per common share (EUR per share) | 0.59 | 0.54 | 0.37 | 0.30 | (0.12) | (0.16) |
|  Basic earnings per common share B (EUR per share) | 0.01 | 0.01 | 0.01 | 0.01 | - | - |

---

**Notes to the unaudited pro forma Consolidated income statement adjustments** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Adjustments to 'Insurance service result'

Adjustments to Insurance service result reflect the elimination of the Insurance revenue and Insurance service expenses of Aegon UK. Insurance revenue mainly comprises expected insurance claims / expenses and CSM release; and Insurance service expenses mainly comprises the actual insurance claims / expenses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*2.* Adjustments to 'Insurance net investment result'

Adjustments to Insurance net investment result reflect the elimination of the Insurance net investment result of Aegon UK. Insurance net investment result mainly comprises share dividends received by Aegon UK (Other investment income); fair value changes on Aegon UK's investments (Results from financial transactions); and the Insurance finance expenses attributable to Aegon UK's insurance contracts.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*3.* Adjustments to 'Other net investment result'

Adjustments to Other net investment result reflect the elimination of the other net investment result of Aegon UK. Other net investment result mainly comprises of fair value changes on Aegon UK's investments related to investment contracts (Results from financial transactions); and the Investment contract expenses attributable to Aegon UK's investment contracts portfolio.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Adjustments to 'Net result from continuing operations'

Adjustments to Net result from continuing operations reflect the elimination of Aegon UK's net result and includes inter-segment results between continuing Aegon Group entities and Aegon UK which are expected to discontinue.

------

**Unaudited pro forma Consolidated statement of financial position of Aegon Ltd.** 

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | | **As of December 31, 2025** | **As of December 31, 2025** | **As of December 31, 2025** |
| Amounts in EUR millions | **Note** | **Historical** | **Pro forma adjustments** | <br> **Pro forma financial<br>information** |
|  Cash and cash equivalents | **5** | 2733 | 623 | 3357 |
|  Investments | **5** | 285141 | (123599) | 161542 |
|  Derivative assets |  | 485 | (48) | 438 |
|  Investments in joint ventures |  | 1566 | - | 1566 |
|  Investments in associates |  | 2638 | - | 2638 |
|  Reinsurance contract assets |  | 17153 | (1) | 17152 |
|  Insurance contract assets |  | 18 | - | 18 |
|  Defined benefit assets |  | 95 | (95) | - |
|  Reimbursement rights |  | 28 | - | 28 |
|  Deferred tax assets |  | 1894 | (69) | 1826 |
|  Deferred expenses and rebates |  | 452 | (14) | 438 |
|  Other assets and receivables | **8** | 4508 | (1190) | 3318 |
|  Intangible assets |  | 519 | (132) | 387 |
|  **Total assets** |  | **317233** | **(124525)** | **192709** |
|  Shareholders' equity | **6** | 7432 | 1119 | 8551 |
|  Other equity instruments |  | 1978 | - | 1978 |
|  **Issued capital and reserves attributable to owners of Aegon Ltd.** |  | **9410** | **1119** | **10529** |
|  Non-controlling interests |  | 85 | - | 85 |
|  **Group equity** |  | **9495** | **1119** | **10614** |
|  Subordinated borrowings |  | 1461 | - | 1461 |
|  Trust pass-through securities |  | 99 | - | 99 |
|  Reinsurance contract liabilities |  | 195 | (4) | 191 |
|  Insurance contract liabilities | **7** | 176067 | (44705) | 131363 |
|  Investment contract liabilities with discretionary participation features | **7** | 21281 | (21269) | 12 |
|  Investment contracts without discretionary participation features | **7** | 97814 | (58644) | 39170 |
|  Derivative liabilities |  | 1469 | (184) | 1285 |
|  Borrowings |  | 1982 | - | 1982 |
|  Provisions |  | 97 | (9) | 88 |
|  Defined benefit liabilities |  | 507 | - | 507 |
|  Deferred revenue liabilities |  | 5 | (5) | - |
|  Deferred tax liabilities |  | 13 | (23) | (10) |
|  Other liabilities | **8** | 6445 | (731) | 5714 |
|  Accruals |  | 303 | (70) | 233 |
|  **Total liabilities** |  | **307738** | **(125644)** | **182094** |
|  **Total equity and liabilities** |  | **317233** | **(124525)** | **192709** |

---

**Notes to the unaudited pro forma Consolidated statement of financial position adjustments** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. Adjustments to 'Cash and cash equivalents' and to 'Investments'

Adjustments to Cash and cash equivalents of EUR 623 million represent the cash consideration to be received from Standard Life at the closing of the transaction (EUR 859 million) which is partially offset by the elimination of Aegon UK's cash amount (EUR 200 million) and an estimate of the cost to be incurred by Aegon to sell the Aegon UK business (EUR 36 million).

Adjustments to Investments of EUR 123,599 million reflect the elimination of Aegon UK's investments (EUR 125,128 million) partially offset by the share consideration to be received from Standard Life at the closing of the transaction.

---

| | | |
|:---|:---|:---|
| **Proceeds** | **GBP millions** | **EUR millions** |
|  Cash | 750 | 859 |
|  Shares | 1335 | 1529 |
|  **Total** | **2085** | **2389** |

---

For the purpose of these unaudited pro forma numbers the 181 million shares to be received is multiplied by the GBP 7.37 closing stock price of Standard Life's shares at the London stock exchange on December 31, 2025. FX conversion rate used is 0.8727, the EUR/GBP closing rate on December 31, 2025.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. Adjustments to 'Shareholders' equity'

Adjustments to Shareholders' equity of EUR 1,119 million reflect the receipt of the expected net consideration from the proposed transaction amounting to EUR 2,353 million offset by the derecognition of Aegon UK from Aegon's consolidated statement of financial position for an amount of EUR 1,234 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. Adjustments to 'Insurance contract liabilities' and to 'Investment contract liabilities with / without
discretionary participation features'

Adjustments to 'Insurance contract liabilities and to Investment contract liabilities with / without discretionary participation features reflect the elimination of Aegon UK's insurance contract liabilities and investment contract liabilities. These liabilities mainly consist of Platform, Packaged and Annuities related contracts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. Adjustments to 'Other assets' and to 'Other liabilities'

Adjustments to Other assets and to Other liabilities reflect the elimination of Aegon UK's other assets and other liabilities.